Approvals/CIMA-AEMPS/SEVIKAR HCT 40 mg/5 mg/25 mg COMPRIMIDOS RECUBIERTOS CON PELICULA

Approved

STANDARD

SEVIKAR HCT 40 mg/5 mg/25 mg COMPRIMIDOS RECUBIERTOS CON PELICULA

Daiichi Sankyo Belgium🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Id: 445bcb45695f4822
Drug Cima Aemps Name: SEVIKAR HCT 40 mg/5 mg/25 mg COMPRIMIDOS RECUBIERTOS CON PELICULA
Register Number: BE387493
Holder Company Name: Daiichi Sankyo Belgium
Marketing Company Name: Elam Pharma Labs S.L.
Authorization Date: 2021-08-25
Dosage Form: COMPRIMIDO RECUBIERTO CON PELÍCULA
Dose: 40 mg/5mg/25 mg
Route Of Administration: VÍA ORAL
Prescription Type: Medicamento Sujeto A Prescripción Médica
Commercialized: Yes
Company Name: Daiichi Sankyo Belgium

OLMESARTAN MEDOXOMILO

40 mg

AMLODIPINO BESILATO

6,944 mg

HIDROCLOROTIAZIDA

25 mg

Approved

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Aug 25, 2021

Approval ID

445bcb45695f4822

Type

Standard